Androgen-independent basal cell re-epithelialization, c-erbB-2 mRNA expression and androgen-dependent EGFr mRNA expression in benign prostatic hyperplasia explant cultures treated with finasteride

Int J Cancer. 1998 May 18;76(4):519-22. doi: 10.1002/(sici)1097-0215(19980518)76:4<519::aid-ijc13>3.0.co;2-2.

Abstract

We have analyzed the effects of the 5alpha-reductase inhibitor, finasteride (MK906), on the mRNA expression of the epidermal growth factor receptor and c-erbB-2 genes, in benign prostatic hyperplasia explant cultures treated with testosterone and with testosterone plus finasteride. A decrease of the epithelial cell content and an androgen-independent basal cell re-epithelialization was observed during the first 10 days of culture, suggesting a role of basal cells as stem cells involved in androgen-independent epithelial regeneration. Using a semi-quantitative reverse transcription polymerase chain reaction technique, we observed a significant decrease in expression of the epidermal growth factor receptor in the cultures treated with finasteride whereas no effect of finasteride on c-erbB-2 transcription was detected, although the expression of both genes was increased by dihydrotestosterone.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cholestenone 5 alpha-Reductase
  • Culture Techniques
  • Enzyme Inhibitors / pharmacology
  • Epithelium / drug effects*
  • ErbB Receptors / metabolism*
  • Finasteride / pharmacology*
  • Gene Expression
  • Humans
  • Male
  • Oxidoreductases / antagonists & inhibitors
  • Polymerase Chain Reaction
  • Prostatic Hyperplasia / metabolism*
  • RNA, Messenger / metabolism
  • Receptor, ErbB-2 / metabolism*
  • Testosterone / pharmacology*

Substances

  • Enzyme Inhibitors
  • RNA, Messenger
  • Testosterone
  • Finasteride
  • Oxidoreductases
  • Cholestenone 5 alpha-Reductase
  • ErbB Receptors
  • Receptor, ErbB-2